Latest news with #IVL
Time of India
27-05-2025
- Business
- Time of India
Swedish Investments To Catapult Vidarbha On Defence, Industry Map
1 2 3 Nagpur: Vidarbha is on the cusp of an industrial transformation with Swedish defence and aerospace companies, heavy industry and tetra-packaging firms expressing interest in setting up manufacturing units in the region. Consul General of Sweden, Sven Ostberg, and his trade and investment team's visit to Nagpur on Tuesday signalled a cutting-edge business push that could establish Vidarbha as a burgeoning defence and industrial hub, capitalizing on its strategic central location in India. Also, there's a move to leverage Swedish expertise to restore the city's Nag river through advanced technology. This could be on the agenda of Ostberg's crucial meeting with the municipal commissioner, Abhijeet Chaudhuri, on Wednesday. Leading Swedish defence and aerospace company Saab AB, known for its advanced military systems, is likely to make a foray into the Nagpur region. Talking exclusively to TOI, Sven Ostberg said, "Saab AB operates a manufacturing plant in Jhajjar, Haryana, and the company is likely to expand its operations in Vidarbha, considering its business potential and geographical advantage." Saab AB's potential entry into the region could catapult Nagpur on to India's defence manufacturing map. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Her body cannot endure this level of pain; please help her. Donate For Health Learn More Undo Alfa Laval, a global leader in heavy industry solutions, is also considering Vidarbha as its next manufacturing unit, building on its existing facility in Pimpri Chinchwad near Pune. The company's expertise in heat transfer, separation, and fluid handling could drive industrial growth in the region, complementing the defence focus with heavy industry development, said a member of the investment team. The Association for Industrial Development (AID) made a compelling case for Swedish investments during a high-profile session with Ostberg on Tuesday at CP Club, attended by Saloni Zaveri, senior advisor, trade and investment promotion with Consulate General of Sweden, IVL country manager, business development and marketing, Rupali Deshmukh, industry leader Ajay Sancheti, correspondent diplomat of Malta, Afzal Mitha, serial entrepreneur Shashikant Chaudhary, IIM director Bhimaraya Metri and Neeri director S Venkata Mohan among others. AID president Ashish Kale emphasized the region's potential to support Swedish investments and Vidarbha's strengths, including its emerging industrial hub of Mihan, to foster bilateral trade, export-import collaborations, and technology exchanges with Sweden. Additionally, IVL, a Swedish Environmental Research Institute, is conducting a pre-feasibility study for a Sweden-India Centre of Excellence (CoE) for Sustainable City/Society in Nagpur. IVL's Rupali Deshmukh noted that CoE could leverage Swedish expertise in water, waste, and energy management, potentially aiding projects like the Nag River restoration through advanced technologies and sustainable practices. "By leveraging Swedish expertise, innovative technologies, and close collaboration with our Indian counterparts, we aim to co-create scalable solutions in water, waste, and energy management that can serve as a model for cities across India. Nagpur's proactive approach and openness to partnership make it an ideal collaborator in this transformative journey," Deshmukh said. She added that the proposed Sweden-India Centre of Excellence has potential to support Nag River restoration by bringing advanced Swedish technology and best practices in wastewater treatment, pollution control, and ecological river restoration. "It will facilitate pilot projects, capacity building, and real-time monitoring while promoting collaboration between Indian authorities and Swedish experts. The CoE will also support integrated river basin management and help develop sustainable solutions aligned with India's river rejuvenation goals," she said.
Yahoo
20-05-2025
- Health
- Yahoo
Shockwave Medical Study Confirms Benefit of IVL-First Strategy in Real-World Female Patients with Complex Calcified Lesions in Late-Breaking Data Presentation at EuroPCR 2025
EMPOWER CAD, a global prospective, multi-center, real-world study, reaffirms favorable acute outcomes for coronary IVL in female patients, unlike other calcium modification tools PARIS, May 20, 2025 /PRNewswire/ -- Shockwave Medical, Inc., part of Johnson & Johnson MedTech and a global leader in the field of circulatory restoration, announced today the 30-day primary endpoint results of EMPOWER CAD, the first prospective, real-world percutaneous coronary intervention (PCI) study in female patients with complex, calcified coronary artery disease. The favorable results confirm the results of earlier retrospective analyses demonstrating the benefits of coronary intravascular lithotripsy (IVL) in female patients. The results were presented in a late-breaking presentation at the annual EuroPCR meeting in Paris. Women with coronary artery calcification (CAC) undergoing PCI are often underrepresented in clinical trials and have historically poorer outcomes than men, including increased risk of adverse clinical outcomes and high rates of procedural complications with other calcium modification treatments, such as rotational or orbital atherectomy.1,2 Investigators designed the EMPOWER CAD study to evaluate real-world outcomes in female patients with severely calcified coronary lesions treated with an IVL-first treatment strategy and confirm positive results from previous studies showing similar safety and effectiveness outcomes across both men and women. EMPOWER CAD is a pivotal study comprised of a series of firsts: Shockwave's first prospective, post-market study of IVL examining an all-comers female population with minimal exclusion criteria, the first study to encourage a Shockwave IVL-first PCI strategy for calcified coronary lesions, and the first study to follow-up with enrolled patients for three years following IVL therapy. The study enrolled 399 participants across 45 sites spanning five countries in the European Union and United States. The study is led by co-principal investigators Margaret McEntegart, M.D., Ph.D., Director of the Complex PCI and CTO programs and Cardiac Catheterization Labs at Columbia University Medical Center/NewYork-Presbyterian Hospital and Alexandra Lansky, M.D., Professor of Medicine in the section of Cardiovascular Medicine and Director, Heart and Vascular Clinical Research Program, Yale University School of Medicine. The study's European lead is Nieves Gonzalo, M.D., Ph.D., consultant interventional cardiologist at Hospital Clinico San Carlos in Madrid, Spain.† "Women are typically underdiagnosed, underrepresented and have underwhelming outcomes in coronary artery disease studies," said Dr. Lansky. "Our goal with the EMPOWER CAD study was to address this gap and determine whether Shockwave IVL should be considered as the front-line calcium modification approach in female patients with complex coronary artery disease. The results demonstrate the benefits of IVL use in this specific patient population and validate findings from previous studies." The primary effectiveness endpoint of procedural success, defined as stent delivery with ≤30% residual stenosis for all treated target lesions without in-hospital target lesion failure (TLF), was 86.9% at 30 days. The primary safety endpoint, defined as TLF as a composite of cardiac death, myocardial infarction attributable to target vessel (TV-MI) or ischemia-driven target lesion revascularization (ID-TLR) within 30 days, was 12.1%. TLF was primary driven by the rate of periprocedural MI3 (10.6%); the majority of these periprocedural MIs were not associated with any clinical signs or symptoms. Cardiac death and ID-TLR rates were each 1.3%. Procedural complications were rare with only one patient (0.2%) having a serious angiographic complication when assessed at the end of the procedure. There were also clinically and statistically significant improvements in health-related quality of life scores at 30 days compared to baselines. "By leveraging a Shockwave IVL-first approach, the EMPOWER CAD 30-day results demonstrated high procedural success, low complication rates and significant improvements in quality of life among real-world female patients," said Dr. McEntegart. "While we look forward to following these patients for the next three years, these primary endpoint results confirm that excellent outcomes can be achieved with the use of Shockwave IVL in women with complex, calcified coronary artery disease." Nick West., M.D., Chief Medical Officer, Shockwave Medical, emphasized the significance of the EMPOWER CAD study, stating, "Today marks a critical milestone in the journey to improve outcomes for female patients with calcified lesions. What began as an idea a few years ago is now a commendable reality today, thanks to study leadership and site investigators accelerating completion and reporting these important results. We're looking forward to learning more about the benefits of IVL therapy in this underrepresented patient population, both acutely and at extended follow-up." About Shockwave MedicalShockwave Medical, Inc., part of Johnson & Johnson MedTech, is a leader in the development and commercialization of innovative products that are transforming the treatment of cardiovascular disease. Its first-of-its-kind Intravascular Lithotripsy (IVL) technology has transformed the treatment of atherosclerotic cardiovascular disease by safely using sonic pressure waves to disrupt challenging calcified plaque, resulting in significantly improved patient outcomes. Its Reducer technology, which is under clinical investigation in the United States and is CE Marked in the European Union and the United Kingdom, is designed to provide relief to the millions of patients worldwide suffering from refractory angina by redistributing blood flow within the heart. Learn more at Cardiovascular Solutions from Johnson & Johnson MedTechAcross Johnson & Johnson, we are tackling the world's most complex and pervasive health challenges. Through a cardiovascular portfolio that provides healthcare professionals with advanced mapping and navigation, miniaturized tech, and precise ablation, we are addressing conditions with significant unmet needs such as heart failure, coronary artery disease, stroke, and atrial fibrillation. We are the global leaders in heart recovery, circulatory restoration and the treatment of heart rhythm disorders, as well as an emerging leader in neurovascular care, committed to taking on two of the leading causes of death worldwide in heart failure and stroke. About Johnson & JohnsonAt Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity. Learn more about our MedTech sector's global scale and deep expertise in cardiovascular, orthopaedics, surgery and vision solutions at Follow us at @JNJMedTech and on LinkedIn. Shockwave Medical, Inc. is part of Johnson & Johnson MedTech. Cautions Concerning Forward-Looking StatementsThis press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Shockwave Medical, Inc. and/or Johnson & Johnson. Risks and uncertainties include, but are not limited to: uncertainty of commercial success; challenges to patents; competition, including technological advances, new products and patents attained by competitors; manufacturing difficulties and delays; product efficacy or safety concerns resulting in product recalls or regulatory action; changes to applicable laws and regulations, including global health care reforms; changes in behavior and spending patterns of purchasers of health care products and services; and trends toward healthcare cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson's most recent Annual Report on Form 10-K, including in the sections captioned "Cautionary Note Regarding Forward-Looking Statements" and "Item 1A. Risk Factors," and in Johnson & Johnson's subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at or on request from Johnson & Johnson. Neither Shockwave Medical, Inc. nor Johnson & Johnson undertakes to update any forward-looking statement as a result of new information or future events or a result of new information or future events or developments. † Drs. McEntegart, Lansky and Gonzalo are paid consultants of Shockwave Medical. They have not been compensated in connection with this press release. 1 Giustino et al., JACC Cardiovasc Int 2016; Ford et al., Catheter Cardiovasc Interv 2020; Hussain et al., JSCAI 2022.2 Kim et al. Catheter Cardiovasc Interv. 20163 As defined by SCAI for periprocedural MI and Fourth Universal (Type 4a) for spontaneous MI beyond discharge. Media Contacts: Lindsey Diaz-MacInnisldiazmac@ Rachael Jarnaginrjarnagi@ Investor Contact:Sandra Easton Investor-relations@ View original content to download multimedia: SOURCE Johnson & Johnson MedTech
Time of India
28-04-2025
- Business
- Time of India
CM explores collaboration with Swedish institute for sustainable development
1 2 The high-level delegation of the Jharkhand govt, under chief minister Hemant Soren, visited the head office of IVL Swedish Environmental Research Institute (IVL) in Stockholm on the last day of its nine-day European tour. They held discussions for mutual cooperation in the fields of water and waste management , environmental technologies , e-mobility, and waste-to-energy initiatives, among others. Apart from the CM, the Indian delegation included his wife and Gandey MLA Kalpana Soren, Jharkhand chief secretary Alka Tiwary, additional chief secretary to the CM, Avinash Kumar, secretary Industries Arava Rajkamal, and director industries Sushant Gaurav. They met the top brass of IVL Swedish Environmental Research Institute, including CEO John Rune Nielsen, chief financial officer Thomas Nilsson, and head of International Projects and CEO of IVL's India R&D Unit. IVL is a research organisation dedicated to promoting sustainable development across ecological, economic, and social dimensions. The institute combines research activities with commissioned work, each representing approximately half of its operations. The organisation employs a diverse team of professionals, including engineers, environmental scientists, behavioural scientists, economists, and social scientists, enabling it to address sustainability challenges from multiple perspectives. Their work spans traditional environmental science to economics and social sciences. A unique aspect of IVL's operation is its co-financed research model, where projects are funded jointly by state funds (through agencies like Formas and the Swedish Environmental Protection Agency) and private businesses or industry organisations. This arrangement ensures practical relevance while maintaining scientific rigour. Key criteria for research projects include relevance to industry or society at large, focus on environmental problems or development potential, equal funding from state and business partners, and public availability of results through IVL's report series or other open channels. The institute maintains transparency through annual reporting to its board and govt agencies, ensuring accountability in both research outcomes and financial management. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Tungurahua: AI guru Andrew Ng recommends: Read These 5 Books And Turn Your Life Aroun... Blinkist: Andrew Ng's Reading List Undo The delegation also met the Indian diaspora at a dinner hosted by the Indian Embassy in Sweden. Soren urged the Indian business representatives to act as ambassadors for India in the Nordics and invited them to explore investment opportunities in Jharkhand.
NZ Herald
27-04-2025
- Business
- NZ Herald
New Tourism Minister Louise Upston on more tourists, higher wages, infrastructure and who pays for it
'I'm not talking about only some visitors and only going to some places. I'm saying, very clearly, we're open for business, anyone, anytime, anywhere. We have capacity,' she told the Herald. 'With the exception of probably one location, we want growth, we want more visitors.' Her exception was the Mackenzie district, which includes hotspots Aoraki National Park and Lake Tekapo, with its small ratepayer base. Queenstown is not in the same category, however, and 'hasn't stopped promoting itself to visitors', even though local authorities estimate the water infrastructure needs at two and a half times the local population. Louise Upston took over the Tourism and Hospitality portfolio in January. Photo / Mark Mitchell Longer term, Upston said there were challenges around what will be needed once tourism numbers have fully recovered, and as the Government looks to continue increasing them. Those costs will need to be shared, especially for mixed-use infrastructure (used by residents and tourists). One way to do this - which Upston supports, and the Government is considering - is charging international visitors an access fee for iconic destinations. That money could then be reinvested into those destinations. She wouldn't be drawn on whether Kiwis should also pay for access. Another way is a bed tax, though Upston said this was off the table for the time being, despite Auckland and Queenstown calling for one. There will be some IVL money for additional investment, rather than for Crown savings, though at this stage she couldn't say how much or what for. 'In the not-too-distant future, I will be announcing the Tourism Growth Roadmap, and that will make it clear what the investment is for the year going forward, and what my plans are beyond that.' There may be additional Government funding, she indicated, at a time when the Government continues to exercise fiscal restraint. Aoraki Mt Cook is part of the Mackenzie district, which has a small base of ratepayers and high numbers of visitors. Photo / George Heard No additional funding yet - but lots of Crown savings The IVL rose from $35 to $100 in October last year, providing an estimated $149m-a-year in additional revenue. It must, by law, be spent on tourism or conservation. Budget 2024 banked $261.9m of this over four years as a funding switch: swapping additional IVL revenue for Crown funding, which improves the Crown finances while maintaining overall investment. An overwhelming majority (84%) of stakeholders object to using the IVL in this way, according to IVL consultation last year. Instead, they want IVL money to add to overall spending. Asked if the IVL-funded initiatives she's announced so far were funding switches rather than additional spending, Upston said: 'That's correct.' Altogether they save the Crown $60.45 million. They include: A $500,000 Tourism NZ campaign to attract tourists from Australia. A $3 million campaign to bring tourists to regional New Zealand over autumn and winter. $30m to support conservation tourism. $2.45m for regional events outside peak times. $9m in contestable funding for the upkeep of the Great Rides network. $3m to secure more business events for New Zealand. $13.5m for Tourism NZ to market the country to China, Australia, the United States, India, Germany and South Korea. A majority (54%) of stakeholder feedback also opposed using IVL money for marketing, which is specifically excluded in the current IVL investment plan. But Upston said the IVL can be used in this way if IVL Ministers (Upston, Conservation Minister Tama Potaka, and Finance Minister Nicola Willis) decide it's a priority, which they did. International arrival numbers are at 86% of pre-pandemic levels. Photo /123RF It's unclear if the $60.45m is additional savings for the Crown or part of the $261.9m banked in Budget 2024. If the latter, there remains an estimated $78m a year in additional IVL revenue that could be used to increase overall spending in conservation or tourism. Tourism and conservation advocates have been waiting for over half a year for a decision on how this might be spent, while the IVL pot has swelled with tens of millions of dollars from the higher rate. Investment priorities, according to Tourism Industry Aotearoa and Local Government NZ, include water and transport infrastructure, while environment and recreational groups point to the needs of the Department of Conservation (DoC). DoC is more than $1.5 billion a year short of what it needs just to meet its biodiversity objectives. It is already trying to meet funding shortfalls by, for example, charging for car parks in hotspots over the 2025/26 summer. This kind of user charge aligns with a 2023 tourism briefing, from the Ministry of Business, Innovation and Employment (MBIE), which said the question of who pays was 'an economic problem rather than a fiscal one'. But Upston indicated the fiscal reserves for tourism weren't empty. Asked if the message to the sector was no more Government money, she said: 'That's not the message. Things will be clearer when the Tourism Growth Roadmap comes out, and we confirm our IVL investments.' Prime Minister Christopher Luxon and Tourism Minister Louise Upston at Weta Workshop Unleashed. Photo / Dean Purcell More tourists, more Kiwi workers, higher wages please Tourism is a central role in Prime Minister Christopher Luxon's focus on economic growth, though many contributing factors are beyond direct Government control including global economic headwinds (such as ongoing tariff uncertainty), and the value of the New Zealand dollar. Appointed in January, Upston spent her first weeks as the new minister meeting with key stakeholders. 'What really impressed me was actually how unified the sector was, and the view very clearly was, job number one, to get back to the numbers of visitors from 2019.' In December 2019, 528,000 international visitors arrived in New Zealand. This fell to 365,000 in December 2022, before rising to 470,000 in December 2024. International visitors spent $12.2 billion in New Zealand in 2024, including $3.2b in the December quarter alone. Adjusted for inflation, this is 86% of 2019 levels. Upston wouldn't put a number on how many more tourists there was capacity for, nor how many she wanted by 2034 to help double export earnings. Tourism Minister Louise Upston supports charging international visitors to certain hotspots, which the Government is currently considering. Milford Sound is one of the proposed places for an access charge. Photo / Supplied Her announcements so far are not surprising. It's long been part of New Zealand's tourism strategy to boost numbers in the off-season and to the regions. Nor is another of her aims surprising: to lift wages and lift productivity in what MBIE describes as a low-wage, weak-productivity sector. 'That doesn't happen overnight,' Upston said. 'When I talk about the long-term goals, I'm looking at workforce issues, I'm looking at the structure of how we operate and promote, how we drive quality - all of those things are important.' Upston said a key goal, after boosting tourism numbers, is to have more New Zealanders working in tourism and hospitality, rather than migrants. Why are Kiwis not especially keen to work in the sector? 'I just don't think the sector's promoted it well enough, for one reason.' She said the low-wage descriptor was unwarranted, but conceded that Government policy allowing businesses to pay migrant workers the minimum wage - rather than the median wage - was affecting tourism wages. 'That's a change in an immigration setting across the board. It's not aimed at one sector.' How to lift wages, then? 'We need to grow tourism businesses. We need to grow the value from the tourism visitors we have. We need to look at other areas in the 'going for growth' sectors applying to tourism, whether it's innovation, whether it's developing talent, whether it's lifting productivity. 'I'm really positive about how the sectors come together, and how we can work on growth and supply and infrastructure challenges in the future.' Sign up to The Daily H, a free newsletter curated by our editors and delivered straight to your inbox every weekday. Derek Cheng is a senior journalist who started at the Herald in 2004. He has worked several stints in the Press Gallery team and is a former deputy political editor.
Barnama
25-04-2025
- Health
- Barnama
Elixir Medical Announces First Use of LithiX Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Asia Pacific at Cardiac Vascular Sentral Kuala Lumpur (CVSKL), Malaysia
MILPITAS, Calif., April 25 (Bernama) -- Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, today announced the first clinical use of its LithiX™ Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in the Asia Pacific region, marking a significant milestone in the device's global introduction. The procedures were successfully performed at Cardiac Vascular Sentral Kuala Lumpur Hospital in Kuala Lumpur by Dr. Tamil Selvan Muthusamy, MD, and Dr. Rosli Mohd Ali, MD. The LithiX™ HC-IVL device represents a novel mechanical approach to calcium modification in calcified coronary lesions, offering the benefits of intravascular lithotripsy using prior technologies without requiring an external energy source. Based on the Hertz Contact Stress principle, the device delivers precise mechanical amplification of force to achieve calcium fractures while minimizing unintended vessel trauma.
